CN106146313A - The preparation method of bexarotene key intermediate - Google Patents
The preparation method of bexarotene key intermediate Download PDFInfo
- Publication number
- CN106146313A CN106146313A CN201510180812.3A CN201510180812A CN106146313A CN 106146313 A CN106146313 A CN 106146313A CN 201510180812 A CN201510180812 A CN 201510180812A CN 106146313 A CN106146313 A CN 106146313A
- Authority
- CN
- China
- Prior art keywords
- pentamethyl
- chloride
- bexarotene
- reaction
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
Abstract
The present invention is the preparation method of key intermediate 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalene) methoxyl group] essence of Niobe (5) about PTS bexarotene.The method of the present invention is with intermediate 1,1,4,4,6-pentamethyl-1,2,3,4-tetrahydronaphthalene (4) directly with chlorinating agent, aluminum chloride and the dichloromethane equal solvent such as commercially available industrial chemicals terephthalic acid monomethyl ester, thionyl chloride or oxalyl chloride, single step reaction i.e. obtains intermediate (5).
Description
Technical field
The present invention relates to the preparation method of a kind of PTS bexarotene key intermediate
Technical background
Bexarotene (Bexarotene) is the new antitumor drug developed by Ligand drugmaker of the U.S., its
Trade nameObtain FDA approval in January, 2000 to list in the U.S..Calendar year 2001 is in Europe city
Field is approved listing.
This medicine optionally combines and activates retinoid X receptor (RXR), promotes RXR and multiple receptor
[such as: retinoid receptor (RAR), vitamin D receptor (VDR) and peroxisome proliferator-activated
Receptor (PPAR) etc.] form heterodimer, thus controlling gene is expressed and the differentiation hypertrophy of cell.At present,
This medicine is mainly used in treating recalcitrant dermal T-cell lymphoma clinically.
The chemical structural formula of bexarotene:
Chemical name: 4-[1-(5,6,7,8-tetrahydrochysene-3,5,5,8,8-pentamethyl-2-naphthyl) vinyl] benzoic acid
Patent US5466861 and document J.Med.Chem.1994 abroad, 37 (18): 2930~2941,
J.Med.Chem.1995, all reports the synthetic method of bexarotene in 38 (17): 3368~3383.With 2,5-
Dimethyl-2,5-hexanediol 2 is initiation material, through chlorination reaction generate 2,5-bis-chloro-2,5-dimethylhexane 3,
Carry out Friedel-Crafts alkylated reaction with toluene, obtain 1, Isosorbide-5-Nitrae, 4,6-pentamethyl-1,2,3,4-tetra-
Hydrogenated naphthalene 4,4 with methoxycarbonyl group Benzenecarbonyl chloride. condensation reaction is obtained 4-[(3,5,5,8,8-pentamethyls
-5,6,7,8-tetrahydrochysene-2-naphthalenes) methoxyl group] essence of Niobe 5, then obtained by Wittig reaction
4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalenes) vinyl] essence of Niobe 6, then by hydrolysis
Reaction obtains 4-[1-(5,6,7,8-tetrahydrochysene-3,5,5,8,8-pentamethyl-2-naphthyl) vinyl] benzoic acid 1 (shellfish
Bimbisara spit of fland).
In document J.Org.Chm.2001,66 (17): 5772~5782 synthetic route reported, only centerings
Method when mesosome 5 prepares 6 changes, and uses methyl grignard reagent, by intermediate 5 methoxy acyl group
Chelation, then by benzene methanesulfonic acid dehydration obtain 6.Other reactions steps are unchanged.
The route of Chinese patent CN1429807A is will abroad to report the last two step exchange orders of route, first will
Intermediate 5 hydrolysis obtains 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalene) carbonyl] benzoic acid first
Acid, then form dehydration after the tertiary alcohol with form reagent reacting and obtain end product bexarotene.
In above three synthetic routes, the synthetic method as key intermediate 5 all uses intermediate 4 with right
Methoxycarbonyl group Benzenecarbonyl chloride. condensation reaction prepares.
And very active to methoxycarbonyl group Benzenecarbonyl chloride. chemical property, should not place for a long time, therefore without commercially available product
Product, general employing is now used existing system, terephthalic acid monomethyl ester is prepared by chlorination reactions such as toxic articles phosphorus pentachlorides.
Due to very active to the chemical property of methoxycarbonyl group Benzenecarbonyl chloride., process after the reaction or Long contact time
Causing decomposition rotten during air, side reaction when making intermediate 4 prepare 5 is more, not only reaction yield low (70%),
And the purity difference of product 5.As can be seen here, literature method not only needs to increase by a step to methoxycarbonyl group Benzenecarbonyl chloride.
Preparation, and reaction yield is low, product purity is poor, so the production cost of bexarotene and refined can be increased
The difficulty of purification, is unfavorable for that industry is big and produces.
Summary of the invention
The present invention is directed to bexarotene key intermediate 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-
Naphthalene) methoxyl group] problem present in essence of Niobe 5 preparation technology, through substantial amounts of test and improvement repeatedly
Research, achieves and is surprisingly found that, it was found that a kind of raw material is easy to get, process route is simple, it is adaptable to industrialization
Big production prepares 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalene) methoxyl group] essence of Niobe 5
Method.
The method of the present invention is by direct for intermediate 4 and commercially available industrial chemicals terephthalic acid monomethyl ester, thionyl chloride
(SOCl2) or oxalyl chloride ((COCl)2) etc. chlorinating agent, aluminum chloride and dichloromethane equal solvent, a step is anti-
Should i.e. obtain bexarotene key intermediate 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalene) first
Epoxide] essence of Niobe 5.
The method of the present invention not only simplify reactions steps, raw material is easy to get, reaction condition gentle, and reacts receipts
Rate is up to 95% (former literature method yield 70%), product purity >=98%, has also sliced off in literature method for surely
Determine the chemical reagent nitromethane hypertoxic, explosive of reactant.Reduce production cost, simplify production technology,
It is particularly suitable for industrialized great production.
The chlorinating agent used in the inventive method can be thionyl chloride (SOCl2), oxalyl chloride ((COCl)2) etc..
The solvent used in the inventive method can be dichloromethane, chloroform, dichloroethanes, toluene, second
Acetoacetic ester etc..
In the inventive method, the charge ratio (mol ratio) of each reactant is intermediate 4: terephthalic acid monomethyl ester:
Chlorinating agent: aluminum chloride=1:0.8-1.5:0.8-1.5:1-4, preferably 1:1:1.2:2.7.
In the inventive method, reaction temperature is 0~100 DEG C, preferably 20~50 DEG C.
In the inventive method, the response time is 1~10 hour, preferably 3~5 hours.
Specific embodiment:
The present invention being explained in more detail with example below, the present invention is not limited in the content of following instance.
Example 1
By terephthalic acid monomethyl ester 120.0g (0.666mol), thionyl chloride 58.0ml (0.799mol), two
Chloromethanes 1500ml and 134.5g (0.666mol) intermediate 4 adds in reaction bulb, stirs, then
Add aluminum chloride 239.6g (1.798mol), add rear room temperature (20 DEG C) stirring reaction 1 hour.Then
It is heated to reflux 3 hours, after concentrating under reduced pressure reactant liquor, cools down and be slowly added into frozen water stirring and dissolving, add acetic acid second
Ester extracts, and separates organic layer, washes secondary, is dried with anhydrous sodium sulfate.Methanol is used after organic layer evaporated under reduced pressure
Recrystallization, filters, is dried to obtain white crystalline powder 231.0g, fusing point: 141-143 DEG C, yield 95.3% (literary composition
Offer J.Med.Chem.1994,37 (18): 2930~2941 report fusing points: 142-143 DEG C, yield: 72%).1H-NMR(CDCl3) δ: 1.29 (6H, s, CH3×2);1.31 (6H, s, CH3×2);1.72 (4H,
S, CH2×2);3.95 (3H, s, COCH3);7.29 (1H, d, J=8Hz, aromatic H);7.46
(1H, d-d, J=2and 8Hz, aromatic H);(7.64 1H, d, J=2Hz, aromatic H);
8.00 (2H, d, J=8Hz, aromatic H);8.13 (2H, d, J=8Hz, aromatic H).
Example 2
By terephthalic acid monomethyl ester 180.0g (0.999mol), oxalyl chloride 85.2ml (0.999mol), trichlorine
Methane 1500ml and 134.5g (0.666mol) intermediate 4 adds in reaction bulb, stirs, then adds
Enter aluminum chloride 355.2g (2.664mol), in 30 DEG C of stirring reactions 1 hour after adding.Then it is heated to reflux
5 hours, after concentrating under reduced pressure reactant liquor, cool down and be slowly added into frozen water stirring and dissolving, add ethyl acetate extraction,
Separate organic layer, wash secondary, be dried with anhydrous sodium sulfate.By recrystallizing methanol after organic layer evaporated under reduced pressure,
Filter, be dried to obtain white crystalline powder 217.0g, fusing point: 141-143 DEG C, yield 89.5% (document
J.Med.Chem.1994,37 (18): 2930~2941 report fusing points: 142-143 DEG C, yield: 72%).1H-NMR(CDCl3) δ: 1.29 (6H, s, CH3×2);1.31 (6H, s, CH3×2);1.72 (4H,
S, CH2×2);3.95 (3H, s, COCH3);7.29 (1H, d, J=8Hz, aromatic H);7.46
(1H, d-d, J=2and 8Hz, aromatic H);(7.64 1H, d, J=2Hz, aromatic H);
8.00 (2H, d, J=8Hz, aromatic H);(8.13 2H, d, J=8Hz, aromatic H).
Example 3
By terephthalic acid monomethyl ester 96.3g (0.533mol), thionyl chloride 38.7ml (0.533mol), first
Benzene 1500ml and 134.5g (0.666mol) intermediate 4 adds in reaction bulb, stirs, is subsequently adding
Aluminum chloride 88.8g (0.666mol), in 50 DEG C of stirring reactions 1 hour after adding.Then 8 it are heated to reflux
Hour, cool down and be slowly added into frozen water stirring and dissolving after concentrating under reduced pressure reactant liquor, add ethyl acetate extraction, point
Go out organic layer, wash secondary, be dried with anhydrous sodium sulfate.By recrystallizing methanol after organic layer evaporated under reduced pressure, mistake
Filter, be dried to obtain white crystalline powder 170.4g, fusing point: 141-143 DEG C, yield 70.3% (document
J.Med.Chem.1994,37 (18): 2930~2941 report fusing points: 142-143 DEG C, yield: 72%).1H-NMR(CDCl3) δ: 1.29 (6H, s, CH3×2);1.31 (6H, s, CH3×2);1.72 (4H,
S, CH2×2);3.95 (3H, s, COCH3);7.29 (1H, d, J=8Hz, aromatic H);7.46
(1H, d-d, J=2and 8Hz, aromatic H);(7.64 1H, d, J=2Hz, aromatic H);
8.00 (2H, d, J=8Hz, aromatic H);(8.13 2H, d, J=8Hz, aromatic H).
Example 4
By terephthalic acid monomethyl ester 120.0g (0.666mol), thionyl chloride 58.0ml (0.799mol), two
Ethyl chloride 1500ml and 134.5g (0.666mol) intermediate 4 adds in reaction bulb, stirs, then
Add aluminum chloride 239.6g (1.798mol), add rear room temperature (25 DEG C) stirring reaction 1 hour.Then
It is heated to reflux 10 hours, after concentrating under reduced pressure reactant liquor, cools down and be slowly added into frozen water stirring and dissolving, add acetic acid
Ethyl ester extracts, and separates organic layer, washes secondary, is dried with anhydrous sodium sulfate.First is used after organic layer evaporated under reduced pressure
Alcohol recrystallization, filters, is dried to obtain white crystalline powder 224.5g, fusing point: 141-143 DEG C, yield 92.6%
(document J.Med.Chem.1994,37 (18): 2930~2941 report fusing points: 142-143 DEG C, yield:
72%).
1H-NMR(CDCl3) δ: 1.29 (6H, s, CH3×2);1.31 (6H, s, CH3×2);1.72 (4H,
S, CH2×2);3.95 (3H, s, COCH3);7.29 (1H, d, J=8Hz, aromatic H);7.46
(1H, d-d, J=2 and 8Hz, aromatic H);7.64 (1H, d, J=2Hz, aromatic H);
(8.00 2H, d, J=8Hz, aromatic H);8.13 (2H, d, J=8Hz, aromatic H).
Claims (6)
1. prepare bexarotene key intermediate 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydrochysene-2-naphthalene) for one kind
Methoxyl group] method of essence of Niobe (5), it is characterized in that with intermediate 1, Isosorbide-5-Nitrae, 4,6-pentamethyl-1,2,3,4-
Tetrahydronaphthalene (4) is raw material, with commercially available industrial chemicals terephthalic acid monomethyl ester, chlorinating agent, aluminum chloride,
Solvent, single step reaction i.e. obtain bexarotene key intermediate 4-[(3,5,5,8,8-pentamethyl-5,6,7,8-tetra-
Hydrogen-2-naphthalene) methoxyl group] essence of Niobe (5),
Method the most according to claim 1, it is characterised in that described chlorinating agent is selected from thionyl chloride, grass
Acyl chlorides.
Method the most according to claim 1, it is characterised in that described solvent is selected from dichloromethane, trichlorine
Methane, dichloroethanes, toluene, ethyl acetate.
Method the most according to claim 1, it is characterised in that the charge ratio (mol ratio) of each reactant is
Intermediate 4: terephthalic acid monomethyl ester: chlorinating agent: aluminum chloride=1:0.8-1.5:0.8-1.5:1-4, is preferably
1:1:1.2:2.7。
Method the most according to claim 1, it is characterised in that reaction temperature is 0~100 DEG C, is preferably
20~50 DEG C.
Method the most according to claim 1, it is characterised in that the response time is 1~10 hour, is preferably
3~5 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510180812.3A CN106146313A (en) | 2015-04-15 | 2015-04-15 | The preparation method of bexarotene key intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510180812.3A CN106146313A (en) | 2015-04-15 | 2015-04-15 | The preparation method of bexarotene key intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106146313A true CN106146313A (en) | 2016-11-23 |
Family
ID=58058024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510180812.3A Pending CN106146313A (en) | 2015-04-15 | 2015-04-15 | The preparation method of bexarotene key intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106146313A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012880A2 (en) * | 1992-11-25 | 1994-06-09 | La Jolla Cancer Research Foundation | Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
CN1429807A (en) * | 2001-12-29 | 2003-07-16 | 中国科学院上海药物研究所 | Synthesis of antitumour medicine bexarotene |
US7655699B1 (en) * | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
WO2011103321A1 (en) * | 2010-02-19 | 2011-08-25 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Novel bexarotene analogs |
WO2011141928A1 (en) * | 2010-05-11 | 2011-11-17 | Ind-Swift Laboratories Limited | Process for the preparation of highly pure bexarotene |
-
2015
- 2015-04-15 CN CN201510180812.3A patent/CN106146313A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655699B1 (en) * | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
WO1994012880A2 (en) * | 1992-11-25 | 1994-06-09 | La Jolla Cancer Research Foundation | Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
CN1429807A (en) * | 2001-12-29 | 2003-07-16 | 中国科学院上海药物研究所 | Synthesis of antitumour medicine bexarotene |
WO2011103321A1 (en) * | 2010-02-19 | 2011-08-25 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Novel bexarotene analogs |
WO2011141928A1 (en) * | 2010-05-11 | 2011-11-17 | Ind-Swift Laboratories Limited | Process for the preparation of highly pure bexarotene |
Non-Patent Citations (2)
Title |
---|
陈笑宇: "贝萨罗汀的合成研究", 《中国优秀硕士学位论文 医药卫生科技辑》 * |
魏玮等: "蓓萨罗丁的合成及优化", 《化学研究与应用》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103384663B (en) | For the preparation of the synthesis of the intermediate of bent of Ansai and derivative thereof | |
CN101735029B (en) | Synthesis method of hellebore aldehyde | |
CN113603568A (en) | Preparation method of cannabidiol | |
CN107337596B (en) | Preparation method of 4-methoxy-1, 3-phthalic acid | |
CN102584618A (en) | Preparation method for 4-substituted acylamino cyclohexanone | |
CN1029680C (en) | Technology for phenyl fluorenol (an antimalarial) synthesis | |
CN102391128B (en) | Production method of antibiotic pharmaceutical intermediate mono-p-nitro benzyl malonate | |
CN102010315A (en) | Method for synthesizing naphthazarin and derivatives thereof | |
CN103102264B (en) | Preparation method of salicylic acid compound | |
CN103772189B (en) | Synthesis method of diethylstilbestrol compound methyl pigeon pea ketonic acid A | |
CN103923040B (en) | A kind of method preparing furfural oxime acid | |
CN106146313A (en) | The preparation method of bexarotene key intermediate | |
CN104262122A (en) | Method for synthesizing 1,4-butene diketone compound | |
CN103804187B (en) | Synthesis method of diethylstilbestrol compound pigeon pea ketonic acid A | |
CN110746323B (en) | Industrial production method of efficient Fmoc-Glu (Otbu) -OH | |
CN102875344B (en) | A kind of preparation method of 2,3,4-TMB | |
CN103709092B (en) | The preparation method of Mitiglinide Calcium | |
CN113072471B (en) | Lifeiste intermediate and preparation method thereof | |
CN106554266B (en) | Preparation method of methoxyphenylacetic acid, intermediate thereof and salt thereof | |
CN103183604B (en) | The preparation method of Vedaprofen | |
CN110452199B (en) | Preparation method of feloxicib | |
CN109836322B (en) | Preparation method of royal jelly acid | |
CN110305016B (en) | One-step preparation of 4-hydroxybenzyl benzaldehyde carbonate | |
CN113004161A (en) | Preparation method of (2R,3R) -3-methyl-3-phenylalanine | |
CN106317001A (en) | Method for preparing polycyclic furan compound through one-pot reaction under conditions of no catalyst and no solvent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161123 |
|
WD01 | Invention patent application deemed withdrawn after publication |